Provence Wealth Management Group Stoke Therapeutics, Inc. Transaction History
Provence Wealth Management Group
- $186 Million
- Q4 2023
A detailed history of Provence Wealth Management Group transactions in Stoke Therapeutics, Inc. stock. As of the latest transaction made, Provence Wealth Management Group holds 470 shares of STOK stock, worth $16,732. This represents 0.0% of its overall portfolio holdings.
Number of Shares
470
Previous 470
-0.0%
Holding current value
$16,732
Previous $1,000
100.0%
% of portfolio
0.0%
Previous 0.0%
Shares
1 transactions
Others Institutions Holding STOK
# of Institutions
138Shares Held
58MCall Options Held
2.7KPut Options Held
57.4K-
Black Rock Inc. New York, NY5.41MShares$193 Million0.0% of portfolio
-
Lynx1 Capital Management LP San Juan, PR5.4MShares$192 Million18.16% of portfolio
-
Rtw Investments, LP New York, NY5.12MShares$182 Million0.89% of portfolio
-
Baker Bros. Advisors LP New York, NY4.63MShares$165 Million0.53% of portfolio
-
Redmile Group, LLC San Francisco, CA4.38MShares$156 Million6.04% of portfolio
About Stoke Therapeutics, Inc.
- Ticker STOK
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 39,419,300
- Market Cap $1.4B
- Description
- Stoke Therapeutics, Inc., an early-stage biopharmaceutical company, develops novel antisense oligonucleotide (ASO) medicines to treat the underlying causes of severe genetic diseases in the United States. The company utilizes its proprietary Targeted Augmentation of Nuclear Gene Output to design ASOs to precisely upregulate protein expression. I...